- This event has passed.
WHO Executive Board Meeting
January 22 - January 27
The World Health Organization will convene the 154th session of the WHO Executive Board in Geneva from 22-27 January 2024.
The Executive Board is composed of 34 technically qualified members elected for three-year terms. The annual Board meeting is held in January when the members agree upon the agenda for the World Health Assembly (scheduled for May 2024) and the resolutions to be considered by the Health Assembly, including the 2025-2028 Programme of Work, sustainable financing, and global health emergency priorities and processes.
Highlighted agenda items (links below) include the Draft Global Action Plan for Infection Prevention and Control; Immunization Agenda; Antimicrobial resistance operational priorities 2025-2035; Smallpox eradication: destruction of variola virus stocks; Public health emergencies: preparedness and response; Strengthening the global architecture for health emergency preparedness, prevention and response and resilience.
Proceedings will be webcast and recorded for on-demand viewing.
The Executive Board
Chair and Officers of the Executive Board
Composition of the Executive Board
EB154/1
Provisional agenda
EB154/1 (annotated)
Provisional agenda (annotated)
EB154/3
Report of the regional committees to the Executive Board
EB154/5
Report of the Standing Committee on Health Emergency Prevention, Preparedness and Response
EB154/6
Universal health coverage
EB154/7
Follow-up to the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases
Prevention and management of noncommunicable diseases, promotion of mental health and well-being, and treatment and care of mental health conditions
EB154/8
Draft global action plan for infection prevention and control
Draft global action plan and monitoring framework
EB154/8 Add.1
Draft global action plan on infection prevention and control
Draft global action plan and monitoring framework: minimum requirements for IPC programmes at national and health care facility levels
EB154/9
Immunization Agenda 2030
Progress towards global immunization goals and implementation of the Immunization Agenda 2030
EB154/10
End TB Strategy
Progress in implementing the global strategy and targets for tuberculosis prevention, care and control after 2015 (the End TB Strategy)
EB154/11
Road map for neglected tropical diseases 2021–2030
EB154/12
Acceleration towards the Sustainable Development Goal targets for maternal health and child mortality
EB154/13
Antimicrobial resistance: accelerating national and global responses
WHO strategic and operational priorities to address drug-resistant bacterial infections in the human health sector, 2025–2035
EB154/14
WHO’s work in health emergencies
Public health emergencies: preparedness and response
EB154/15
WHO’s work in health emergencies
Strengthening the global architecture for health emergency preparedness, prevention and response and resilience
EB154/16
Implementation of resolution WHA75.11 (2022)
EB154/17
Global Health and Peace Initiative
EB154/18
Poliomyelitis
Poliomyelitis eradication
EB154/19
Poliomyelitis
Polio transition planning and polio post-certification
EB154/20
Smallpox eradication: destruction of variola virus stocks
EB154/21
Social determinants of health
Progress of the World Report on Social Determinants of Health Equity
EB154/23
Well-being and health promotion
EB154/24
Climate change, pollution and health
Impact of chemicals, waste and pollution on human health
EB154/25
Climate change and health
EB154/27
Financing and implementation of the Programme budget 2022–2023 and outlook on financing of the Programme budget 2024–2025
EB154/28
Draft fourteenth general programme of work
EB154/29 Rev.1
Sustainable financing: WHO investment round
EB154/32
Matters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary, Programmatic and Financing Governance
Secretariat implementation plan on reform
EB154/33
Matters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary, Programmatic and Financing Governance
Strengthening WHO’s budgetary, programmatic and financing governance: follow-up to the implementation of decision EB152(15) (2023)
EB154/33 Add.1
Matters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary, Programmatic and Financing Governance
Proposals for improving the effectiveness of the WHO Governing bodies
EB154/33 Add.2
Matters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary, Programmatic and Financing Governance
Project plan: implementation of digital solutions for interactions between the Secretariat and Member States on matters related to the governing bodies
EB154/33 Add.3
Matters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary, Programmatic and Financing Governance
Cost recovery mechanisms for voluntary contributions – an update
EB154/34
Matters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary, Programmatic and Financing Governance
EB154/34 Add.1
Matters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary, Programmatic and Financing Governance
Follow-up to decision WHA69(8) (2016), operative paragraph (10)
EB154/34 Add.2
Matters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary, Programmatic and Financing Governance
Proposed methodology for costing new initiatives/programmes
EB154/36
Engagement with non-State actors
Report on the implementation of the Framework of Engagement with Non-State Actors
EB154/37
Engagement with non-State actors
Non-State actors in official relations with WHO
EB154/37 Add.1
Financial and administrative implications for the Secretariat of decisions proposed for adoption by the Executive Board
EB154/38
Nomination and appointment of Regional Directors
Process for the election of Regional Directors
EB154/39
Provisional agenda of the Seventy-seventh World Health Assembly
EB154/50
Report on meetings of expert committees and study groups
Report by the Director-General
EB154/50 Add.1
Report on meetings of expert committees and study groups
Expert advisory panels and committees and their membership